Kyoto, Japan

Keiichi Higano

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyoto Electronics Manufacturing Company, Limited. Active years: 2008.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiichi Higano: Innovator in Dioxin Detection

Introduction

Keiichi Higano is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for detecting harmful substances.

Latest Patents

Higano holds a patent for a recombinant antibody that recognizes dioxin, specifically 2,3,4,7,8-pentachlorodibenzofuran (2,3,4,7,8-PeCDF). This invention encompasses a novel recombinant antibody with binding activity to 2,3,4,7,8-PeCDF, a gene encoding its amino acid sequence, and a vector that incorporates this gene. The patent also details a transformant that is transformed with the vector, a process for preparing the recombinant antibody, and methods for immunologically capturing and determining 2,3,4,7,8-PeCDF using the antibody. This technology allows for rapid, convenient, and highly sensitive detection of dioxins.

Career Highlights

Higano is associated with Kyoto Electronics Manufacturing Company, Limited, where he applies his expertise in biotechnology. His work focuses on developing advanced detection methods that can significantly impact environmental safety and public health.

Collaborations

Higano collaborates with esteemed colleagues such as Kazuyuki Sawadaishi and Chiwa Kataoka. Their combined efforts contribute to the advancement of innovative solutions in the field of dioxin detection.

Conclusion

Keiichi Higano's work in developing a recombinant antibody for dioxin detection exemplifies the importance of innovation in biotechnology. His contributions not only enhance detection methods but also promote environmental safety.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…